Work

Supplementary Table 3 from Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders

Year: 2023
Type: supplementary-materials
Abstract: Supplemental Table 3: Plasma and urine cfDNA mutation detection zscores for KRAS (G12A, G12C, G12D, G12R, G12S, G12V, G13D) with tissue biopsy KRASG12 genotyping from patient with Erdheim-Chester Disease (ECD).
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362550663
Cites:
Cited by:
Related to: 10